Accueil・Liste d'Actions・NeoGenomics Inc

NeoGenomics Inc

Ouvert

SecteurSoins de santé

18.92 0.37

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

18.71

Max

19.32

Chiffres clés
By Trading Economics
Revenu	19M 2.2M
Ventes	15M 202M
BPA	-0.01
Marge bénéficiaire	1.11
Employés	2,500
EBITDA	19M 19M

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	-2.95% downside

Dividendes
By Acuity
Prochains Résultats	27 oct. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	654M 2.4B
Ouverture précédente	18.55
Clôture précédente	18.92

Sentiment de l'Actualité

By Acuity

76%

24%

304 / 339 Classement par Healthcare

NeoGenomics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

15 sept. 2026, 20:07 UTC

Neogenomics Inc's shares are higher today, reflecting a notable increase since Monday's close. The stock remains above its 20-day moving average.

14 sept. 2026, 23:46 UTC

Neogenomics Inc shares are modestly higher in after-market trading, maintaining a position above its 20-day moving average and near the top of its one-month range.

11 sept. 2026, 21:01 UTC

Neogenomics Inc shares declined in after-market trading, coinciding with a significant drop in the Michigan Consumer Sentiment Index. No specific company news was identified.

10 sept. 2026, 20:07 UTC

Neogenomics Inc shares are lower today amid a broader market decline and rising Treasury yields, with no specific company news identified.

9 sept. 2026, 20:07 UTC

Neogenomics Inc's shares are higher Wednesday, despite an earlier pullback. No specific company news was identified to explain the price movement.

8 sept. 2026, 19:26 UTC

Neogenomics Inc shares are higher today, continuing gains since Friday. The stock remains above its 20-day moving average and within its one-month range.

4 sept. 2026, 23:20 UTC

Neogenomics Inc shares are higher in after-market trading, reflecting strong performance since Friday's close and positioning above its 20-day moving average.

2 sept. 2026, 20:08 UTC

Neogenomics Inc is lower in Wednesday's session, continuing a trend of four consecutive declines. No specific news was identified to explain the move.

1 sept. 2026, 20:08 UTC

Neogenomics Inc shares are lower today, continuing a downward trend since Monday. No specific company news was identified to explain the decline.

31 août 2026, 20:07 UTC

Social Media

Neogenomics Inc shares are lower amid rising interest rate hike expectations following recent economic commentary. Earlier, the stock rebounded from a session high.

28 août 2026, 20:51 UTC

Neogenomics Inc's shares are higher in after-market hours, moving significantly above their 20-day moving average and near the upper end of their one-month range.

27 août 2026, 23:01 UTC

Neogenomics Inc. shares are higher in after-market trading, reflecting notable strength following Thursday's close. The stock remains above its 20-day moving average.

26 août 2026, 23:01 UTC

News

Neogenomics Inc secures expanded Medicare coverage for RaDaR ST assay, enhancing immunotherapy monitoring. Shares are trading higher in after-market hours.

25 août 2026, 23:02 UTC

Neogenomics Inc is trading higher in after-market hours, remaining near the upper end of its one-month range and above its 20-day moving average.

24 août 2026, 23:06 UTC

Neogenomics Inc shares are lower in after-market trading, with no specific news identified. Broader market concerns include the U.S.-Iran conflict and oil supply disruptions.

21 août 2026, 20:06 UTC

Neogenomics shares are higher, benefiting from a strong trend in the Health Care Services sub-sector, despite no specific company news identified.

20 août 2026, 21:26 UTC

Neogenomics Inc's shares are higher in after-market trading, maintaining a stable performance since Thursday's close amid no specific news or developments.

19 août 2026, 19:26 UTC

Neogenomics Inc shares are higher today amid strong buying interest. The stock is approaching the upper end of its one-month trading range.

18 août 2026, 19:36 UTC

Neogenomics Inc shares are lower today amid broader economic concerns, including rising treasury yields and inflation pressures. The stock reached a session low earlier.

17 août 2026, 22:01 UTC

Neogenomics Inc is rising in after-market trading, reflecting a strong performance following Monday's close amid a generally positive trading environment and heightened volatility.

14 août 2026, 23:01 UTC

Neogenomics Inc shares are lower in after-market hours, following a decline influenced by mixed market sentiment and a drop in U.S. retail sales.

13 août 2026, 22:02 UTC

Neogenomics Inc. shares fell in after-market trading, declining since Thursday's close, despite broader market averages closing higher earlier in the day.

12 août 2026, 23:51 UTC

Neogenomics Inc shares are higher in after-market trading, maintaining a strong upward trajectory since Wednesday's close, despite no specific news identified.

11 août 2026, 19:26 UTC

Neogenomics Inc. shares are lower today, with no specific news identified. Investors await U.S. inflation reports that may impact market sentiment.

10 août 2026, 22:26 UTC

Neogenomics Inc shares are higher in after-market trading, remaining above their 20-day moving average despite no specific news. Rising Treasury yields may influence sentiment.

7 août 2026, 20:03 UTC

Neogenomics Inc shares are higher during Friday's session, reflecting strong market performance. The stock has advanced since Thursday's close, despite a recent pullback.

6 août 2026, 21:51 UTC

Neogenomics Inc shares are higher in after-market trading, reaching a notable high and remaining above their 20-day moving average. No specific news was identified.

5 août 2026, 19:36 UTC

Neogenomics Inc shares are lower today, reversing earlier gains despite no specific news. Broader market sentiment reflects easing inflation concerns amid declining crude oil prices.

4 août 2026, 19:33 UTC

Social Media

Neogenomics Inc. shares are higher amid social media discussions on long-term investment strategies, despite negative narratives about the company's performance.

3 août 2026, 20:03 UTC

Neogenomics Inc shares are higher today, reflecting overall market momentum. The S&P 500 and Nasdaq 100 also posted gains during the session.

Comparaison

Variation de prix

NeoGenomics Inc prévision

Objectif de Prix

By TipRanks

-2.95% baisse

Prévisions sur 12 Mois

Moyen 18.333 USD -2.95%

Haut 21 USD

Bas 16 USD

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

8 ratings

Achat

Maintien

Vente

Basé sur 8 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Sentiment

By Acuity

304 / 339Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.